Literature DB >> 9296498

p73 is a simian [correction of human] p53-related protein that can induce apoptosis.

C A Jost1, M C Marin, W G Kaelin.   

Abstract

The protein p53 is the most frequently mutated tumour suppressor to be identified so far in human cancers. The ability of p53 to inhibit cell growth is due, at least in part, to its ability to bind to specific DNA sequences and activate the transcription of target genes such as that encoding the cell-cycle inhibitor p21Waf1/Cip1 . A gene has recently been identified that is predicted to encode a protein with significant amino-acid sequence similarity to p53. In particular, each of the p53 amino-acid residues implicated in direct sequence-specific DNA binding is conserved in this protein. This gene, called p73, maps to the short arm of chromosome 1, and is found in a region that is frequently deleted in neuroblastomas. Here we show that p73 can, at least when overproduced, activate the transcription of p53-responsive genes and inhibit cell growth in a p53-like manner by inducing apoptosis (programmed cell death).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9296498     DOI: 10.1038/38298

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  252 in total

1.  Identification and classification of p53-regulated genes.

Authors:  J Yu; L Zhang; P M Hwang; C Rago; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis.

Authors:  J Wu; L Gu; H Wang; N E Geacintov; G M Li
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

3.  p53 Family members p63 and p73 are SAM domain-containing proteins.

Authors:  C D Thanos; J U Bowie
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

4.  Identification of a sequence element from p53 that signals for Mdm2-targeted degradation.

Authors:  J Gu; D Chen; J Rosenblum; R M Rubin; Z M Yuan
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  MDM2 suppresses p73 function without promoting p73 degradation.

Authors:  X Zeng; L Chen; C A Jost; R Maya; D Keller; X Wang; W G Kaelin; M Oren; J Chen; H Lu
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  The human p73 promoter: characterization and identification of functional E2F binding sites.

Authors:  Ratnam S Seelan; Meredith Irwin; Petra van der Stoop; Chiping Qian; William G Kaelin; Wanguo Liu
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

7.  Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.

Authors:  Takahito Nakagawa; Masato Takahashi; Toshinori Ozaki; Ken-ichi Watanabe Ki; Satoru Todo; Hiroyuki Mizuguchi; Takao Hayakawa; Akira Nakagawara
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

8.  Transcriptional activities of p73 splicing variants are regulated by inter-variant association.

Authors:  Y Ueda; M Hijikata; S Takagi; T Chiba; K Shimotohno
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

9.  Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.

Authors:  Hideki Shimodaira; Atsuko Yoshioka-Yamashita; Richard D Kolodner; Jean Y J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

10.  Mutation and expression of the p51 gene in human lung cancer.

Authors:  M Tani; K Shimizu; C Kawahara; T Kohno; O Ishimoto; S Ikawa; J Yokota
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.